{"transactions":[{"id":998772,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-11-14T21:10:00.000Z","date":"2025-11-12","kind":"exercise","planned":false,"acquired":false,"shares":19853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":9.33,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":19853},"source":{"system":"sec-edgar","filing":"0001560152-25-000004","document":"form4-11142025_091156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000156015225000004/form4-11142025_091156.xml","form_type":"4"}},{"id":998771,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-11-14T21:10:00.000Z","date":"2025-11-12","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":16.49,"expiration_date":"2026-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001560152-25-000004","document":"form4-11142025_091156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000156015225000004/form4-11142025_091156.xml","form_type":"4"}},{"id":998770,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:10:00.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":34853,"price":47.2136,"value":1645535.6008,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.805 to $47.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":64634,"source":{"system":"sec-edgar","filing":"0001560152-25-000004","document":"form4-11142025_091156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000156015225000004/form4-11142025_091156.xml","form_type":"4"}},{"id":998769,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:10:00.000Z","date":"2025-11-12","kind":"exercise","planned":false,"acquired":true,"shares":19853,"price":9.33,"value":185228.49,"ownership":{"direct":true},"balance_after":99487,"source":{"system":"sec-edgar","filing":"0001560152-25-000004","document":"form4-11142025_091156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000156015225000004/form4-11142025_091156.xml","form_type":"4"}},{"id":998768,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:10:00.000Z","date":"2025-11-12","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":16.49,"value":247350.0,"ownership":{"direct":true},"balance_after":79634,"source":{"system":"sec-edgar","filing":"0001560152-25-000004","document":"form4-11142025_091156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000156015225000004/form4-11142025_091156.xml","form_type":"4"}},{"id":1142359,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T21:43:54.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":9791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":64634,"source":{"system":"sec-edgar","filing":"0001062993-25-009810","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325009810/form4.xml","form_type":"4"}},{"id":1514043,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-16T23:22:21.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":7693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 16, 2025, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":54843,"source":{"system":"sec-edgar","filing":"0001062993-24-010539","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324010539/form4.xml","form_type":"4"}},{"id":1884329,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T20:39:04.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":9792,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 18, 2024, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock."}],"balance_after":47150,"source":{"system":"sec-edgar","filing":"0001062993-23-011816","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299323011816/form4.xml","form_type":"4"}},{"id":2259745,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-23T20:43:43.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":14035,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 19, 2023, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock."}],"balance_after":37358,"source":{"system":"sec-edgar","filing":"0001062993-22-013301","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299322013301/form4.xml","form_type":"4"}},{"id":2697292,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-25T20:51:10.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":3587,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":40.6,"exercise_date":"2018-04-30","expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":3587},"source":{"system":"sec-edgar","filing":"0001127602-21-018010","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760221018010/form4.xml","form_type":"4"}},{"id":2697291,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-25T20:51:10.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":2235,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":28.87,"exercise_date":"2017-04-30","expiration_date":"2026-05-11","underlying":"Common Stock","underlying_shares":2235},"source":{"system":"sec-edgar","filing":"0001127602-21-018010","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760221018010/form4.xml","form_type":"4"}},{"id":2697290,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-25T20:51:10.000Z","date":"2021-05-21","kind":"sale","acquired":false,"shares":3587,"price":253.205,"value":908246.335,"ownership":{"direct":true},"balance_after":14498,"source":{"system":"sec-edgar","filing":"0001127602-21-018010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760221018010/form4.xml","form_type":"4"}},{"id":2697289,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-25T20:51:10.000Z","date":"2021-05-21","kind":"sale","acquired":false,"shares":2235,"price":253.6055,"value":566808.2925,"ownership":{"direct":true},"balance_after":18085,"source":{"system":"sec-edgar","filing":"0001127602-21-018010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760221018010/form4.xml","form_type":"4"}},{"id":2697288,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-25T20:51:10.000Z","date":"2021-05-21","kind":"exercise","acquired":true,"shares":3587,"price":40.6,"value":145632.2,"ownership":{"direct":true},"balance_after":20320,"source":{"system":"sec-edgar","filing":"0001127602-21-018010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760221018010/form4.xml","form_type":"4"}},{"id":2697287,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-25T20:51:10.000Z","date":"2021-05-21","kind":"exercise","acquired":true,"shares":2235,"price":28.87,"value":64524.45,"ownership":{"direct":true},"balance_after":16733,"source":{"system":"sec-edgar","filing":"0001127602-21-018010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760221018010/form4.xml","form_type":"4"}},{"id":2698583,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T21:20:52.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":9941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2022, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock."}],"balance_after":23323,"source":{"system":"sec-edgar","filing":"0001192482-21-000457","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000457/edgar.xml","form_type":"4"}},{"id":2978770,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:41:31.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":21289,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21289},"source":{"system":"sec-edgar","filing":"0001104659-20-126318","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126318/a4.xml","form_type":"4"}},{"id":2978769,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:41:31.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":17326,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17326},"source":{"system":"sec-edgar","filing":"0001104659-20-126318","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126318/a4.xml","form_type":"4"}},{"id":2978768,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:41:31.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":7543,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7543},"source":{"system":"sec-edgar","filing":"0001104659-20-126318","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126318/a4.xml","form_type":"4"}},{"id":2978767,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:41:31.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":10110,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10110},"source":{"system":"sec-edgar","filing":"0001104659-20-126318","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126318/a4.xml","form_type":"4"}},{"id":2978766,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:41:31.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":12787,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12787},"source":{"system":"sec-edgar","filing":"0001104659-20-126318","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126318/a4.xml","form_type":"4"}},{"id":2978765,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:41:31.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":3575,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3575},"source":{"system":"sec-edgar","filing":"0001104659-20-126318","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126318/a4.xml","form_type":"4"}},{"id":2978764,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:41:31.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":2534,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2534},"source":{"system":"sec-edgar","filing":"0001104659-20-126318","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126318/a4.xml","form_type":"4"}},{"id":2978763,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T15:41:31.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Immediately prior to the Effective Time, each Company option that was outstanding (whether vested or unvested) and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Company option (any such Company option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Company option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of the Merger Consideration over the per share exercise price of such Company option. All Company options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001104659-20-126318","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126318/a4.xml","form_type":"4"}},{"id":2978762,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-17T15:41:31.000Z","date":"2020-11-16","kind":"disposition_to_issuer","acquired":false,"shares":37362,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 1, 2020, by and among the Issuer, Covis Group S.a.r.l. (\"Parent\"), and Covis Mergerco Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), and (in respect of specific matters) Covis Finco S.a r.l., pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\") effective as of November 16, 2020 (the \"Effective Time\"). Immediately prior to the Effective Time, each issued and outstanding share of common stock of the Issuer (each, a \"Share\") was cancelled and converted into the right to receive $13.75 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F2","text":"A portion of this amount consists of unvested restricted stock units (\"RSUs\"). Each Company RSU that is outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash from Parent or the Issuer equal to the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 1, 2020, by and among the Issuer, Covis Group S.a.r.l. (\"Parent\"), and Covis Mergerco Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), and (in respect of specific matters) Covis Finco S.a r.l., pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\") effective as of November 16, 2020 (the \"Effective Time\"). Immediately prior to the Effective Time, each issued and outstanding share of common stock of the Issuer (each, a \"Share\") was cancelled and converted into the right to receive $13.75 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"A portion of this amount consists of unvested restricted stock units (\"RSUs\"). Each Company RSU that is outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and automatically converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash from Parent or the Issuer equal to the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-126318","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000110465920126318/a4.xml","form_type":"4"}},{"id":2990001,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-06T21:05:23.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2235,"derivative":{"exercise_price":28.87,"exercise_date":"2017-04-30","expiration_date":"2026-05-11","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001127602-20-028354","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760220028354/form4.xml","form_type":"4"}},{"id":2990000,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-11-06T21:05:23.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":3000,"price":230,"value":690000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan."}],"balance_after":14498,"source":{"system":"sec-edgar","filing":"0001127602-20-028354","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760220028354/form4.xml","form_type":"4"}},{"id":2989999,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-11-06T21:05:23.000Z","date":"2020-11-04","kind":"exercise","acquired":true,"shares":3000,"price":28.87,"value":86610.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan."}],"balance_after":17498,"source":{"system":"sec-edgar","filing":"0001127602-20-028354","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760220028354/form4.xml","form_type":"4"}},{"id":2995093,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-03T21:05:39.000Z","date":"2020-11-02","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2015, 25% of the total award vesting on April 30, 2016 and 25% of the total award vesting on April 30, 2017, subject to continued service as a director or consultant."}],"balance_after":0,"derivative":{"exercise_price":35.11,"expiration_date":"2024-06-02","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001127602-20-027995","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760220027995/form4.xml","form_type":"4"}},{"id":2995092,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-11-03T21:05:39.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":4000,"price":225,"value":900000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan."}],"balance_after":14498,"source":{"system":"sec-edgar","filing":"0001127602-20-027995","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760220027995/form4.xml","form_type":"4"}},{"id":2995091,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-11-03T21:05:39.000Z","date":"2020-11-02","kind":"exercise","acquired":true,"shares":4000,"price":35.11,"value":140440.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan."}],"balance_after":18498,"source":{"system":"sec-edgar","filing":"0001127602-20-027995","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760220027995/form4.xml","form_type":"4"}},{"id":3122739,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-04T16:49:54.000Z","date":"2020-06-02","kind":"grant","acquired":true,"shares":21289,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's 2020 annual meeting of stockholders."}],"balance_after":21289,"derivative":{"exercise_price":8.52,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":21289},"source":{"system":"sec-edgar","filing":"0000792977-20-000060","document":"wf-form4_159130377601364.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297720000060/wf-form4_159130377601364.xml","form_type":"4"}},{"id":3122738,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-04T16:49:54.000Z","date":"2020-06-02","kind":"grant","acquired":true,"shares":10269,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's 2019 Equity Incentive Plan (the \"Plan\") that will vest in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's 2020 annual meeting of stockholders; however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":37362,"source":{"system":"sec-edgar","filing":"0000792977-20-000060","document":"wf-form4_159130377601364.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297720000060/wf-form4_159130377601364.xml","form_type":"4"}},{"id":3129298,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-06-01T20:57:04.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":1029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\").  RSUs vest in full on April 30, 2021 and are settled in shares of common stock on a one-for-one basis."}],"balance_after":14498,"source":{"system":"sec-edgar","filing":"0001127602-20-018247","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760220018247/form4.xml","form_type":"4"}},{"id":3136889,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-05-22T20:23:17.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":8095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable on May 20, 2021, subject to the director's continued service with the issuer."}],"balance_after":8095,"derivative":{"exercise_price":22.05,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":8095},"source":{"system":"sec-edgar","filing":"0001192482-20-000364","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000364/edgar.xml","form_type":"4"}},{"id":3136888,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-22T20:23:17.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":4047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 20, 2021, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock."}],"balance_after":13382,"source":{"system":"sec-edgar","filing":"0001192482-20-000364","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000364/edgar.xml","form_type":"4"}},{"id":3366309,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-19T21:08:37.000Z","date":"2019-11-18","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is subject to the following vesting schedule: 50% of the total award shall vest on April 30, 2014, 25% of the total award shall vest on April 30, 2015 and 25% of the total award shall vest on April 30, 2016, subject to continued service as a director or consultant."}],"balance_after":0,"derivative":{"exercise_price":30.04,"expiration_date":"2023-06-03","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001127602-19-033198","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219033198/form4.xml","form_type":"4"}},{"id":3366308,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-19T21:08:37.000Z","date":"2019-11-18","kind":"exercise","acquired":false,"shares":5525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2016, 25% of the total award vesting on April 30, 2017 and 25% of the total award vesting on April 30, 2018, subject to continued service as a director or consultant."}],"balance_after":0,"derivative":{"exercise_price":27.37,"expiration_date":"2025-05-13","underlying":"Common Stock","underlying_shares":5525},"source":{"system":"sec-edgar","filing":"0001127602-19-033198","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219033198/form4.xml","form_type":"4"}},{"id":3366307,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-19T21:08:37.000Z","date":"2019-11-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% of the total award vesting on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant."}],"balance_after":0,"derivative":{"exercise_price":21.35,"expiration_date":"2022-11-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-19-033198","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219033198/form4.xml","form_type":"4"}},{"id":3366306,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-19T21:08:37.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":9525,"price":181.4087,"value":1727917.8675,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average sale price of the shares sold.  The shares were sold at varying prices in the range of $181.18 to $182.82.  The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":13469,"source":{"system":"sec-edgar","filing":"0001127602-19-033198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219033198/form4.xml","form_type":"4"}},{"id":3366305,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-19T21:08:37.000Z","date":"2019-11-18","kind":"exercise","acquired":true,"shares":4000,"price":30.04,"value":120160.0,"ownership":{"direct":true},"balance_after":22994,"source":{"system":"sec-edgar","filing":"0001127602-19-033198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219033198/form4.xml","form_type":"4"}},{"id":3366304,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-19T21:08:37.000Z","date":"2019-11-18","kind":"exercise","acquired":true,"shares":5525,"price":27.37,"value":151219.25,"ownership":{"direct":true},"balance_after":18994,"source":{"system":"sec-edgar","filing":"0001127602-19-033198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219033198/form4.xml","form_type":"4"}},{"id":3366303,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-19T21:08:37.000Z","date":"2019-11-15","kind":"sale","acquired":false,"shares":5000,"price":180.065,"value":900325.0,"ownership":{"direct":true},"balance_after":13469,"source":{"system":"sec-edgar","filing":"0001127602-19-033198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219033198/form4.xml","form_type":"4"}},{"id":3366302,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-19T21:08:37.000Z","date":"2019-11-15","kind":"exercise","acquired":true,"shares":5000,"price":21.35,"value":106750.0,"ownership":{"direct":true},"balance_after":18469,"source":{"system":"sec-edgar","filing":"0001127602-19-033198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219033198/form4.xml","form_type":"4"}},{"id":3504979,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-06-03T21:37:56.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":1726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual equity award in the form of restricted stock units (\"RSUs\").  RSUs vest in full on April 30, 2020 and are settled in shares of common stock on a one-for-one basis."}],"balance_after":13469,"source":{"system":"sec-edgar","filing":"0001127602-19-020531","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219020531/form4.xml","form_type":"4"}},{"id":3519540,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-20T07:27:29.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":17326,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's 2019 annual meeting of stockholders."}],"balance_after":17326,"derivative":{"exercise_price":10.78,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":17326},"source":{"system":"sec-edgar","filing":"0000792977-19-000104","document":"wf-form4_155835163385617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000104/wf-form4_155835163385617.xml","form_type":"4"}},{"id":3519539,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-20T07:27:29.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":8116,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's 2019 Equity Incentive Plan (the \"Plan\") that will vest in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's 2019 annual meeting of stockholders; however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":27093,"source":{"system":"sec-edgar","filing":"0000792977-19-000104","document":"wf-form4_155835163385617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000104/wf-form4_155835163385617.xml","form_type":"4"}},{"id":3546547,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2019-04-29T22:55:43.000Z","date":"2019-04-25","kind":"grant","acquired":true,"shares":9414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable on April 25, 2020, subject to the director's continued service with the issuer."}],"balance_after":9414,"derivative":{"exercise_price":14.57,"expiration_date":"2029-04-25","underlying":"Common Stock","underlying_shares":9414},"source":{"system":"sec-edgar","filing":"0001192482-19-000222","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000222/edgar.xml","form_type":"4"}},{"id":3546546,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-29T22:55:43.000Z","date":"2019-04-25","kind":"grant","acquired":true,"shares":4707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on April 25, 2020, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the issuer, in shares of the issuer's common stock."}],"balance_after":9335,"source":{"system":"sec-edgar","filing":"0001192482-19-000222","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000222/edgar.xml","form_type":"4"}},{"id":3581793,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-22T20:16:20.000Z","date":"2019-03-20","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% of the total award vesting on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant."}],"balance_after":5000,"derivative":{"exercise_price":21.35,"expiration_date":"2022-11-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-19-012921","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219012921/form4.xml","form_type":"4"}},{"id":3581792,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-22T20:16:20.000Z","date":"2019-03-20","kind":"sale","acquired":false,"shares":5000,"price":100,"value":500000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,185 restricted stock units granted on May 16, 2018, which vest on April 30, 2019, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":11743,"source":{"system":"sec-edgar","filing":"0001127602-19-012921","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219012921/form4.xml","form_type":"4"}},{"id":3581791,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-22T20:16:20.000Z","date":"2019-03-20","kind":"exercise","acquired":true,"shares":5000,"price":21.35,"value":106750.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,185 restricted stock units granted on May 16, 2018, which vest on April 30, 2019, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":16743,"source":{"system":"sec-edgar","filing":"0001127602-19-012921","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219012921/form4.xml","form_type":"4"}},{"id":3595690,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-14T21:06:33.000Z","date":"2019-03-12","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% of the total award vesting on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant."}],"balance_after":10000,"derivative":{"exercise_price":21.35,"expiration_date":"2022-11-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-19-011377","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219011377/form4.xml","form_type":"4"}},{"id":3595689,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-14T21:06:33.000Z","date":"2019-03-12","kind":"sale","acquired":false,"shares":5000,"price":95,"value":475000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,185 restricted stock units granted on May 16, 2018, which vest on April 30, 2019, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":11743,"source":{"system":"sec-edgar","filing":"0001127602-19-011377","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219011377/form4.xml","form_type":"4"}},{"id":3595688,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-14T21:06:33.000Z","date":"2019-03-12","kind":"exercise","acquired":true,"shares":5000,"price":21.35,"value":106750.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,185 restricted stock units granted on May 16, 2018, which vest on April 30, 2019, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":16743,"source":{"system":"sec-edgar","filing":"0001127602-19-011377","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219011377/form4.xml","form_type":"4"}},{"id":3604480,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-08T21:06:52.000Z","date":"2019-03-06","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% of the total award vesting on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant."}],"balance_after":15000,"derivative":{"exercise_price":21.35,"expiration_date":"2022-11-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-19-010579","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219010579/form4.xml","form_type":"4"}},{"id":3604479,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-08T21:06:52.000Z","date":"2019-03-06","kind":"sale","acquired":false,"shares":10000,"price":92.64,"value":926400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,185 restricted stock units granted on May 16, 2018, which vest on April 30, 2019, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":11743,"source":{"system":"sec-edgar","filing":"0001127602-19-010579","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219010579/form4.xml","form_type":"4"}},{"id":3604478,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-08T21:06:52.000Z","date":"2019-03-06","kind":"exercise","acquired":true,"shares":10000,"price":21.35,"value":213500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,185 restricted stock units granted on May 16, 2018, which vest on April 30, 2019, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":21743,"source":{"system":"sec-edgar","filing":"0001127602-19-010579","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760219010579/form4.xml","form_type":"4"}},{"id":3857003,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-01T17:07:34.000Z","date":"2018-07-30","kind":"sale","acquired":false,"shares":2373,"price":58.86,"value":139674.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Column 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person to cover tax liabilities arising out of the vesting of shares of restricted stock."}],"balance_after":33767,"source":{"system":"sec-edgar","filing":"0001209191-18-044763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919118044763/doc4.xml","form_type":"4"}},{"id":3859180,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-30T19:38:43.000Z","date":"2018-07-26","kind":"grant","acquired":true,"shares":3230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy."}],"balance_after":36140,"source":{"system":"sec-edgar","filing":"0001209191-18-044482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919118044482/doc4.xml","form_type":"4"}},{"id":3900919,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-08T16:09:19.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":7543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's annual meeting of stockholders."}],"balance_after":7543,"derivative":{"exercise_price":24.45,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":7543},"source":{"system":"sec-edgar","filing":"0000792977-18-000037","document":"wf-form4_152848854041879.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297718000037/wf-form4_152848854041879.xml","form_type":"4"}},{"id":3900918,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T16:09:19.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":3578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Fourth Amended & Restated 2007 Equity Incentive Plan, as amended (the \"Plan\") that will vest in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's annual meeting of stockholders, however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":18977,"source":{"system":"sec-edgar","filing":"0000792977-18-000037","document":"wf-form4_152848854041879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297718000037/wf-form4_152848854041879.xml","form_type":"4"}},{"id":3915231,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-05-29T21:08:37.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":4506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable on May 24, 2019, subject to the director's continued service with the issuer."}],"balance_after":4506,"derivative":{"exercise_price":24.95,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":4506},"source":{"system":"sec-edgar","filing":"0001192482-18-000256","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000256/edgar.xml","form_type":"4"}},{"id":3915230,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-29T21:08:37.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":2253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 24, 2019, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date in shares of the issuer's common stock."}],"balance_after":4628,"source":{"system":"sec-edgar","filing":"0001192482-18-000256","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000256/edgar.xml","form_type":"4"}},{"id":3926063,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-18T21:52:08.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":2185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 2,185 restricted stock units vest on April 30, 2019, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":11743,"source":{"system":"sec-edgar","filing":"0001127602-18-018181","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218018181/form4.xml","form_type":"4"}},{"id":3992922,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-03-16T22:25:07.000Z","date":"2018-03-14","kind":"sale","acquired":false,"shares":200,"price":84.165,"value":16833.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,010 restricted stock units granted on May 13, 2015, which vest on April 30, 2018; and 2,709 restricted stock units granted on May 17, 2017, which vest on April 30, 2018, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":9558,"source":{"system":"sec-edgar","filing":"0001127602-18-011891","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218011891/form4.xml","form_type":"4"}},{"id":3992921,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-03-16T22:25:07.000Z","date":"2018-03-14","kind":"sale","acquired":false,"shares":8800,"price":84.1,"value":740080.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,010 restricted stock units granted on May 13, 2015, which vest on April 30, 2018; and 2,709 restricted stock units granted on May 17, 2017, which vest on April 30, 2018, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":9758,"source":{"system":"sec-edgar","filing":"0001127602-18-011891","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760218011891/form4.xml","form_type":"4"}},{"id":4248572,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-31T17:20:29.000Z","date":"2017-07-27","kind":"grant","acquired":true,"shares":5273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy."}],"balance_after":32910,"source":{"system":"sec-edgar","filing":"0001209191-17-046734","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919117046734/doc4.xml","form_type":"4"}},{"id":4304499,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2017-05-25T20:33:37.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":19853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on May 24, 2018, subject to the director's continued service with the issuer."}],"balance_after":19853,"derivative":{"exercise_price":9.33,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":19853},"source":{"system":"sec-edgar","filing":"0001192482-17-000135","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248217000135/edgar.xml","form_type":"4"}},{"id":4310948,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-22T19:12:19.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":10110,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's annual meeting of stockholders."}],"balance_after":10110,"derivative":{"exercise_price":19.25,"expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":10110},"source":{"system":"sec-edgar","filing":"0001179110-17-007790","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017007790/edgar.xml","form_type":"4"}},{"id":4310947,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-22T19:12:19.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":4545,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Fourth Amended & Restated 2007 Equity Incentive Plan (the \"Plan\") that will vest in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's annual meeting of stockholders, however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":15399,"source":{"system":"sec-edgar","filing":"0001179110-17-007790","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017007790/edgar.xml","form_type":"4"}},{"id":4313838,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-18T21:36:08.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":3587,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3587,"derivative":{"exercise_price":40.6,"exercise_date":"2018-04-30","expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":3587},"source":{"system":"sec-edgar","filing":"0001127602-17-018705","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760217018705/form4.xml","form_type":"4"}},{"id":4313837,"issuer":{"id":3516,"kind":"organization","name":"INSULET CORP","symbol":"PODD"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-18T21:36:08.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":2709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 2,709 restricted stock units vest on April 30, 2018, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,010 restricted stock units granted on May 13, 2015, which vest on April 30, 2018, subject to continued service as a director or consultant.  Vested shares will be delivered to the reporting person as soon as practicable following a vesting date."}],"balance_after":18558,"source":{"system":"sec-edgar","filing":"0001127602-17-018705","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1145197/000112760217018705/form4.xml","form_type":"4"}}]}